Anti-YTHDF1 antibody [R05-2E7] (STJA0035410)

SKU:
STJA0035410
£133.50 - £281.50
Processing The item has been added

Short Description :Rabbit monoclonal anti-YTHDF1 for use in WB and IP in Human and Hamster samples. Datasheet included with dilution recommendations, and related reagents.
Applications:WB/IP
Host:Rabbit
Reactivity:Human/Hamster
Note:STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Clonality :Monoclonal
Clone ID :R05-2E7
Isotype:IgG
Conjugation:Unconjugated
Concentration:0.3 mg/mL
Purification:Affinity Purified
Dilution Range:WB 1:500-1:1000
IP 1:20
Formulation:50mM Tris-Glycine (pH 7.4) , 0.15M NaCl, 40% Glycerol, 0.01% Sodium azide and 0.05% BSA
Storage Instruction:Store at 4°C short term. Aliquot and store at-20°C long term. Avoid freeze/thaw cycles.
Gene Symbol:Ythdf1
Gene ID:228994
Uniprot ID:YTHD1_MOUSE
Immunogen:Recombinant protein of mouse YTHDF1
Tissue Specificity In brain, preferentially expressed in the hippocampus.
Post Translational Modifications Ubiquitinated by the CUL7-FBXW8 E3 ligase complex leading to degradation. Deubiquitinated and stabilized by USP5 by removing 'Lys-11'-linked polyubiquitination.
Function Specifically recognizes and binds N6-methyladenosine (m6A)-containing mRNAs, and regulates their stability. M6A is a modification present at internal sites of mRNAs and some non-coding RNAs and plays a role in mRNA stability and processing. Acts as a regulator of mRNA stability by promoting degradation of m6A-containing mRNAs via interaction with the CCR4-NOT complex. The YTHDF paralogs (YTHDF1, YTHDF2 and YTHDF3) share m6A-containing mRNAs targets and act redundantly to mediate mRNA degradation and cellular differentiation. Required to facilitate learning and memory formation in the hippocampus by binding to m6A-containing neuronal mRNAs. Acts as a regulator of axon guidance by binding to m6A-containing ROBO3 transcripts. Acts as a negative regulator of antigen cross-presentation in myeloid dendritic cells. In the context of tumorigenesis, negative regulation of antigen cross-presentation limits the anti-tumor response by reducing efficiency of tumor-antigen cross-presentation. Promotes formation of phase-separated membraneless compartments, such as P-bodies or stress granules, by undergoing liquid-liquid phase separation upon binding to mRNAs containing multiple m6A-modified residues: polymethylated mRNAs act as a multivalent scaffold for the binding of YTHDF proteins, juxtaposing their disordered regions and thereby leading to phase separation. The resulting mRNA-YTHDF complexes then partition into different endogenous phase-separated membraneless compartments, such as P-bodies, stress granules or neuronal RNA granules.
Protein Name Yth Domain-Containing Family Protein 1
Dermatomyositis Associated With Cancer Putative Autoantigen 1 Homolog
Daca-1 Homolog
Database Links
Cellular Localisation Cytoplasm
P-Body
Stress Granule
Alternative Antibody Names Anti-Yth Domain-Containing Family Protein 1 antibody
Anti-Dermatomyositis Associated With Cancer Putative Autoantigen 1 Homolog antibody
Anti-Daca-1 Homolog antibody
Anti-Ythdf1 antibody

Information sourced from Uniprot.org